CJC + Ipamorelin blend

A

The CJC without DAC plus ipamorelin blend pairs a GHRH-style analogue with a ghrelin-receptor secretagogue to study coordinated, pulse-like GH-axis signaling.

What is CJC + Ipamorelin blend?

The CJC without DAC plus ipamorelin blend pairs a GHRH-style analogue with a ghrelin-receptor secretagogue to study coordinated, pulse-like GH-axis signaling.

CJC + Ipamorelin blend dosage snapshot

Route
subQ
Dose range
100-300 mcg each
Frequency
daily or 5x weekly
Duration
8-12 weeks

Based on reported research sources; not a dosing instruction.

Potential benefits

  • Recovery support
  • Tissue repair
  • Mobility
  • Body composition
  • Training adaptation

Safety profile

Unknown risk
  • Common: Route-specific irritation or tolerability issues may be reported depending on the compound.
  • Less common: Headache, fatigue, appetite changes, or GI discomfort can appear in community or study contexts.
  • Caution: Risk depends on dose, route, study model, duration, compound quality, and whether human data exists.

Storage and handling

Store according to product-label instructions and batch handling notes. Lyophilized research peptides are commonly kept dry, protected from light, and handled with clean laboratory technique.

Related peptides